

2154. Oral Oncol. 2016 Mar;54:e7-9. doi: 10.1016/j.oraloncology.2015.12.006. Epub 2016 
Jan 8.

FGFR1 amplification and co-overexpression of c-MYC in oropharyngeal squamous cell
carcinoma.

Ozretić L(1), Wagner S(2), Huebbers CU(3), Gattenlöhner S(4), Klussmann JP(2),
Beutner D(5), Zander T(6), Buettner R(7), Quaas A(7).

Author information: 
(1)Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Electronic address: luka.ozretic@uk-koeln.de.
(2)Department of Otorhinolaryngology, Head and Neck Surgery, University of
Giessen, Giessen, Germany.
(3)Jean-Uhrmacher Institute for Oto-Rhino-Laryngological Research, University of 
Cologne, Cologne, Germany.
(4)Institute of Pathology, University Hospital Giessen and Marburg,
Justus-Liebig-University Giessen, Giessen, Germany.
(5)Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital 
Cologne, Cologne, Germany.
(6)Department of Internal Medicine I, Centre for Integrated Oncology, University 
Hospital Cologne, Cologne, Germany.
(7)Institute of Pathology, University Hospital Cologne, Cologne, Germany.

DOI: 10.1016/j.oraloncology.2015.12.006 
PMID: 26778475  [Indexed for MEDLINE]
